Abstract
Objective
Allergic rhinitis (AR) is a growing public health problem worldwide. Respecting the significance of the modified Lund-Kennedy (MLK) score in rhinitis assessment, we delved into its evaluation value on the sublingual immunotherapy (SLIT) efficacy in AR patients.
Methods
Totally 100 AR patients were enrolled, with pre- and post-SLIT MLK score, total nasal symptoms score (TNSS), total medication score (TMS), visual analogue scale (VAS), inflammatory cytokines, and immune function-related parameters compared. The correlations of MLK score with TNSS/TMS/VAS, as well as with IL-4/INF-γ/eosinophil (EOS)/percentage/specific immunoglobulin (sIgE)/sIgG were assessed by Spearman correlation analysis. The value of MLK score on assessing SLIT efficacy in AR patients was analyzed.
Results
SLIT treatment reduced MLK/TNSS/TMS/VAS scores, abated IL-4 level/EOS percentage/sIgE, and elevated INF-γ/sIgG levels. MLK score was positively correlated with pre- and post-SLIT TNSS score (rpre−treatment = 0.592, rpost−treatment = 0.756), TMS score (rpre−treatment = 0.385, rpost−treatment = 0.718), VAS score (rpre−treatment = 0.369, rpost−treatment = 0.704), IL-4 (rpre−treatment = 0.553, rpost−treatment = 0.639), EOS percentage (rpre−treatment = 0.511, rpost−treatment = 0.632), and sIgE (rpre−treatment = 0.472, rpost−treatment = 0.524), and negatively with INF-γ (rpre−treatment = −0.418, rpost−treatment = −0.578) and sIgG4 (rpre−treatment = −0.460, rpost−treatment = −0.613). The MLK score had an area under curve of 0.846 (77.01% sensitivity, 76.92% specificity, 4 cut-off value) and 0.944 (91.67% sensitivity, 92.11% specificity, 2 cut-off value) for assessing SLIT treatment as effective and markedly effective for the patients, respectively.
Conclusion
The MLK score had good evaluation value on the efficacy of SLIT treatment in AR patients.
Keywords
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
